Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2007-01-16
2007-01-16
Fubara, Blessing (Department: 1618)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C424S400000, C514S557000
Reexamination Certificate
active
11173922
ABSTRACT:
The present invention features a novel therapy for effecting acute treatment of migraine headache. The therapy involves intravenous administration of valproate and is equal to and in some respects superior to previously-known therapies for abortive treatment of prolonged moderate to severe acute migraine headache.
REFERENCES:
patent: 5102913 (1992-04-01), Halikas
patent: 5432176 (1995-07-01), Walser
patent: 5767117 (1998-06-01), Moskowitz
patent: WO-99/66920 (1999-12-01), None
patent: WO-00/66109 (2000-11-01), None
Welch, “Drug Therapy: Drug Therapy Migraiine,” The New England Journal of Medicine, Nov. 11, 1993, pp. 1476-1483.
Arnold, G., et al., “Valproic acid in the prophylactic treatment of migraine,”Nervenarzt, vol. 69(10):913-918 (1998).
Curtrer, F.M., et al., “Possible mechanisms of valproate in migraine prophylaxis,”Cephalagia, vol. 17:93-100 (1997).
Edwards, Keith R., et al., “Sodium valproate for the treatment of chronic daily headaches,”Cephalagia, vol. 19:453 (1999), Abstract No. VI-G5-1.
Edwards, Keith R., et al., “Acute Treatment of Migraine Headeach with Intravenous Valproate (Depecon),”Epilepsia, vol. 40(Suppl. 7):143 (1999), Abstract No. 2,240.
Edwards, Keith R, et al., “Intravenous valproate for abortive treatment of acute migraine headache. Is there an anti-convulsant mechanism?”Epilepsia, vol. 40(Suppl. 2):36 (1999).
Edwards, Keith R, “Intravenous valproate for acute treatment of migraine headache,”Cephalalgia, vol. 19:356 (1999), Abstract No. II-GI-7.
Hering, R., et al., “Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo,”Cephalalgia, vol. 12:81-84 (1992).
Jensen, R., et al., “Sodium valproate has a prophylactic effect in migraine worhour aura: a triple-blind, placebo-controlled crossover study,”Neurology, vol. 44:647-651 (1994).
Mathew, Ninan T., et al., “Repetitive intravenous administration of valproate sodium in intractable migraine: Comparison with intravenous Dihydroegotamine (DHE).”Neurology, vol. 54(Suppl. 3):A22 (2000).
Mathew, Ninan T., et al., “Migraine prophylaxis with divalproex,”Arch Neurol, vol. 17:281-286 (1995).
Ramsay, R.E., et al., “The tolerability and safty of valproate sodium injectino given as an intravenous infusion,”Journal of Epilepsy, vol. 10(4):187-193 (1997).
Tran, Bihn N., et al., “Can valproate prevent migraine headache?”Journal of Pharmacy Technology, vol. 13(4):163-168 (1997).
“Intravenous valproate sodium for intractible mitraine,”Journal of Pharmacy Technology, vol. 16(4):161 (2000).
Edwards, Keith R., et al., “Intravenous Valproate For Acute Treatment Of Migraine Headache,”Headache, vol. 39(5):201 (1999), Poster #76.
Kailasam, J., et al., “Intravenous Valproate Sodium (Depacon) Aborts Migraine Rapidly: A Preliminary Report,”Headache, vol. 39(5):168-169 (1999).
Depacon™: Valproate Sodium Injection, Abbott Laboratories 06-9798-R2, Jan. 1998; (No. 1564).
DeConti, Jr. Esq. Giulio A.
Fubara Blessing
Lahive & Cockfield LLP
Milasincic Esq. Debra J.
LandOfFree
Intravenous valproate for acute treatment of migraine headache does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intravenous valproate for acute treatment of migraine headache, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intravenous valproate for acute treatment of migraine headache will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3756671